Form 4: Rhythm Pharmaceuticals Director Exercises Stock Options
SEC Form 4 Filing
Director Christophe Jean exercised options to acquire 3,000 shares of Rhythm Pharmaceuticals common stock on June 21, 2024.
Summary
- On June 21, 2024, Christophe Jean, a director of Rhythm Pharmaceuticals, exercised options to acquire 3,000 shares of common stock.
- The transaction was reported on June 25, 2024.
- The restricted stock units fully vested on June 21, 2024 and have no expiration date.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard disclosure of a director exercising stock options.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 06/21/2024 | Date of transaction: Director exercised options for 3,000 shares of common stock and the restricted stock units fully vested. |
| 06/25/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.